Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botox in Obstructed Defecation Syndrome
NCT02160288Phase 2Terminated
- Sponsor
- Massachusetts General Hospital
- Start
- Feb 2016
- Primary completion
- Jun 2019
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of botulinum toxin type A in obstructed defecation syndrome (ODS), sponsored by Massachusetts General Hospital. Started Feb 2016; status: terminated.
02
Drugs
botulinum toxin type A
03
Conditions
obstructed defecation syndrome (ODS)
Beyond the preview
Go deeper on NCT02160288.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02160288.